Clinical trials

Completed

A phase 2 multicenter, randomized, open label, parallel assignment, pilot study to assess the efficacy and safety of reparixin following islet transplantation in patients with type 1 diabetes mellitus.

REP0110

What is the purpose of this study?

The objective of this clinical trial was to explore the efficacy of reparixin in preventing graft dysfunction after islet transplantation in type 1 diabetes patients (T1D).

Trial overview

Condition

Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus

Study Identifiers

NCT01220856

Study type

Interventional

Intervention

Drug: Reparixin

Phase

II

Start date

Jul 2010

End Date

Apr2013

Enrollment Goal

9 patients

Going deep into the trial

Eligibility/Recruitment

Age

 
18
 
65

Gender

Accepts healthy volunteers

Key Criteria

close

Inclusion

close

Exclusion

Desired Outcomes

close

Primary Outcomes

close

Secondary Outcomes

Find your nearest centre:

Loading...

loading...